nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—CYP2D6—epilepsy syndrome	0.434	1	CbGaD
Midodrine—ADRA1A—hindbrain—epilepsy syndrome	0.00103	0.0814	CbGeAlD
Midodrine—ADRA1D—forebrain—epilepsy syndrome	0.000988	0.0784	CbGeAlD
Midodrine—ADRA1D—telencephalon—epilepsy syndrome	0.000908	0.0721	CbGeAlD
Midodrine—CYP2D6—hindbrain—epilepsy syndrome	0.000604	0.0479	CbGeAlD
Midodrine—ADRA1A—brainstem—epilepsy syndrome	0.000588	0.0467	CbGeAlD
Midodrine—ADRA1B—head—epilepsy syndrome	0.000578	0.0459	CbGeAlD
Midodrine—ADRA1A—forebrain—epilepsy syndrome	0.000567	0.045	CbGeAlD
Midodrine—ADRA1D—head—epilepsy syndrome	0.000566	0.0449	CbGeAlD
Midodrine—ADRA1B—nervous system—epilepsy syndrome	0.000548	0.0435	CbGeAlD
Midodrine—ADRA1D—nervous system—epilepsy syndrome	0.000536	0.0426	CbGeAlD
Midodrine—ADRA1B—central nervous system—epilepsy syndrome	0.000528	0.0419	CbGeAlD
Midodrine—ADRA1A—telencephalon—epilepsy syndrome	0.000522	0.0414	CbGeAlD
Midodrine—ADRA1D—central nervous system—epilepsy syndrome	0.000516	0.041	CbGeAlD
Midodrine—ADRA1B—brain—epilepsy syndrome	0.000419	0.0333	CbGeAlD
Midodrine—ADRA1D—brain—epilepsy syndrome	0.00041	0.0325	CbGeAlD
Midodrine—CYP2D6—brainstem—epilepsy syndrome	0.000346	0.0275	CbGeAlD
Midodrine—CYP2D6—forebrain—epilepsy syndrome	0.000334	0.0265	CbGeAlD
Midodrine—ADRA1A—head—epilepsy syndrome	0.000325	0.0258	CbGeAlD
Midodrine—ADRA1A—nervous system—epilepsy syndrome	0.000308	0.0244	CbGeAlD
Midodrine—CYP2D6—telencephalon—epilepsy syndrome	0.000307	0.0244	CbGeAlD
Midodrine—ADRA1A—central nervous system—epilepsy syndrome	0.000297	0.0235	CbGeAlD
Midodrine—Pruritus—Levetiracetam—epilepsy syndrome	0.000293	0.00075	CcSEcCtD
Midodrine—Dysuria—Topiramate—epilepsy syndrome	0.000292	0.000749	CcSEcCtD
Midodrine—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000292	0.000748	CcSEcCtD
Midodrine—Urethral disorder—Gabapentin—epilepsy syndrome	0.000292	0.000747	CcSEcCtD
Midodrine—Chills—Pregabalin—epilepsy syndrome	0.000291	0.000745	CcSEcCtD
Midodrine—Insomnia—Lamotrigine—epilepsy syndrome	0.00029	0.000743	CcSEcCtD
Midodrine—ADRA1A—cerebellum—epilepsy syndrome	0.00029	0.023	CbGeAlD
Midodrine—Headache—Acetazolamide—epilepsy syndrome	0.000289	0.00074	CcSEcCtD
Midodrine—Pollakiuria—Topiramate—epilepsy syndrome	0.000289	0.00074	CcSEcCtD
Midodrine—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000289	0.000739	CcSEcCtD
Midodrine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000288	0.000738	CcSEcCtD
Midodrine—Abdominal pain—Zonisamide—epilepsy syndrome	0.000287	0.000735	CcSEcCtD
Midodrine—Agitation—Valproic Acid—epilepsy syndrome	0.000287	0.000735	CcSEcCtD
Midodrine—Asthenia—Fosphenytoin—epilepsy syndrome	0.000287	0.000734	CcSEcCtD
Midodrine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000287	0.000734	CcSEcCtD
Midodrine—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000287	0.000734	CcSEcCtD
Midodrine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000286	0.000733	CcSEcCtD
Midodrine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000286	0.000732	CcSEcCtD
Midodrine—Somnolence—Lamotrigine—epilepsy syndrome	0.000285	0.00073	CcSEcCtD
Midodrine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000285	0.00073	CcSEcCtD
Midodrine—Mental disorder—Pregabalin—epilepsy syndrome	0.000284	0.000728	CcSEcCtD
Midodrine—Pain—Carbamazepine—epilepsy syndrome	0.000284	0.000727	CcSEcCtD
Midodrine—Dizziness—Propofol—epilepsy syndrome	0.000283	0.000726	CcSEcCtD
Midodrine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000283	0.000724	CcSEcCtD
Midodrine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000283	0.000724	CcSEcCtD
Midodrine—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000282	0.000723	CcSEcCtD
Midodrine—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000281	0.00072	CcSEcCtD
Midodrine—Asthenia—Vigabatrin—epilepsy syndrome	0.00028	0.000716	CcSEcCtD
Midodrine—Flatulence—Pregabalin—epilepsy syndrome	0.000278	0.000713	CcSEcCtD
Midodrine—Dizziness—Midazolam—epilepsy syndrome	0.000277	0.00071	CcSEcCtD
Midodrine—Tension—Pregabalin—epilepsy syndrome	0.000277	0.00071	CcSEcCtD
Midodrine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000277	0.000709	CcSEcCtD
Midodrine—Abdominal pain—Clonazepam—epilepsy syndrome	0.000277	0.000709	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000276	0.000708	CcSEcCtD
Midodrine—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000276	0.000707	CcSEcCtD
Midodrine—Pruritus—Vigabatrin—epilepsy syndrome	0.000276	0.000706	CcSEcCtD
Midodrine—Asthenia—Diazepam—epilepsy syndrome	0.000275	0.000704	CcSEcCtD
Midodrine—Pain—Lamotrigine—epilepsy syndrome	0.000274	0.000702	CcSEcCtD
Midodrine—Nervousness—Pregabalin—epilepsy syndrome	0.000274	0.000702	CcSEcCtD
Midodrine—Nausea—Acetazolamide—epilepsy syndrome	0.000274	0.000702	CcSEcCtD
Midodrine—Dizziness—Levetiracetam—epilepsy syndrome	0.000274	0.000701	CcSEcCtD
Midodrine—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000274	0.0007	CcSEcCtD
Midodrine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000274	0.0007	CcSEcCtD
Midodrine—Back pain—Pregabalin—epilepsy syndrome	0.000273	0.000699	CcSEcCtD
Midodrine—Stomatitis—Topiramate—epilepsy syndrome	0.000272	0.000696	CcSEcCtD
Midodrine—Muscle spasms—Pregabalin—epilepsy syndrome	0.000272	0.000695	CcSEcCtD
Midodrine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000272	0.000695	CcSEcCtD
Midodrine—Pruritus—Diazepam—epilepsy syndrome	0.000271	0.000695	CcSEcCtD
Midodrine—Rash—Propofol—epilepsy syndrome	0.00027	0.000692	CcSEcCtD
Midodrine—Dermatitis—Propofol—epilepsy syndrome	0.00027	0.000691	CcSEcCtD
Midodrine—Hypertension—Valproic Acid—epilepsy syndrome	0.00027	0.000691	CcSEcCtD
Midodrine—Headache—Propofol—epilepsy syndrome	0.000269	0.000687	CcSEcCtD
Midodrine—Chills—Gabapentin—epilepsy syndrome	0.000267	0.000683	CcSEcCtD
Midodrine—Asthenia—Felbamate—epilepsy syndrome	0.000266	0.000682	CcSEcCtD
Midodrine—Anxiety—Valproic Acid—epilepsy syndrome	0.000265	0.000679	CcSEcCtD
Midodrine—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000264	0.000677	CcSEcCtD
Midodrine—Rash—Midazolam—epilepsy syndrome	0.000264	0.000677	CcSEcCtD
Midodrine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000264	0.000677	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000264	0.000676	CcSEcCtD
Midodrine—Dermatitis—Midazolam—epilepsy syndrome	0.000264	0.000676	CcSEcCtD
Midodrine—Headache—Midazolam—epilepsy syndrome	0.000263	0.000672	CcSEcCtD
Midodrine—Pruritus—Felbamate—epilepsy syndrome	0.000263	0.000672	CcSEcCtD
Midodrine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000262	0.000672	CcSEcCtD
Midodrine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000262	0.000672	CcSEcCtD
Midodrine—Rash—Levetiracetam—epilepsy syndrome	0.000261	0.000668	CcSEcCtD
Midodrine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000261	0.000668	CcSEcCtD
Midodrine—Asthenia—Zonisamide—epilepsy syndrome	0.000261	0.000667	CcSEcCtD
Midodrine—Mental disorder—Gabapentin—epilepsy syndrome	0.000261	0.000667	CcSEcCtD
Midodrine—Dry mouth—Valproic Acid—epilepsy syndrome	0.00026	0.000666	CcSEcCtD
Midodrine—Agitation—Pregabalin—epilepsy syndrome	0.00026	0.000664	CcSEcCtD
Midodrine—Headache—Levetiracetam—epilepsy syndrome	0.000259	0.000664	CcSEcCtD
Midodrine—Dizziness—Vigabatrin—epilepsy syndrome	0.000258	0.000659	CcSEcCtD
Midodrine—Confusional state—Valproic Acid—epilepsy syndrome	0.000257	0.000658	CcSEcCtD
Midodrine—Pruritus—Zonisamide—epilepsy syndrome	0.000257	0.000658	CcSEcCtD
Midodrine—Flatulence—Gabapentin—epilepsy syndrome	0.000255	0.000653	CcSEcCtD
Midodrine—Bradycardia—Topiramate—epilepsy syndrome	0.000255	0.000652	CcSEcCtD
Midodrine—Nausea—Propofol—epilepsy syndrome	0.000255	0.000652	CcSEcCtD
Midodrine—Tension—Gabapentin—epilepsy syndrome	0.000254	0.000651	CcSEcCtD
Midodrine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000254	0.000649	CcSEcCtD
Midodrine—Dizziness—Diazepam—epilepsy syndrome	0.000254	0.000649	CcSEcCtD
Midodrine—Rash—Fosphenytoin—epilepsy syndrome	0.000252	0.000645	CcSEcCtD
Midodrine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000252	0.000644	CcSEcCtD
Midodrine—Nervousness—Gabapentin—epilepsy syndrome	0.000252	0.000644	CcSEcCtD
Midodrine—Asthenia—Clonazepam—epilepsy syndrome	0.000251	0.000643	CcSEcCtD
Midodrine—Back pain—Gabapentin—epilepsy syndrome	0.000251	0.000641	CcSEcCtD
Midodrine—Headache—Fosphenytoin—epilepsy syndrome	0.00025	0.000641	CcSEcCtD
Midodrine—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.00025	0.00064	CcSEcCtD
Midodrine—Asthenia—Phenytoin—epilepsy syndrome	0.00025	0.000639	CcSEcCtD
Midodrine—Nausea—Midazolam—epilepsy syndrome	0.000249	0.000638	CcSEcCtD
Midodrine—Muscle spasms—Gabapentin—epilepsy syndrome	0.000249	0.000637	CcSEcCtD
Midodrine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000249	0.000637	CcSEcCtD
Midodrine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000248	0.000635	CcSEcCtD
Midodrine—Pruritus—Clonazepam—epilepsy syndrome	0.000248	0.000634	CcSEcCtD
Midodrine—Skin disorder—Valproic Acid—epilepsy syndrome	0.000248	0.000634	CcSEcCtD
Midodrine—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000247	0.000633	CcSEcCtD
Midodrine—Pruritus—Phenytoin—epilepsy syndrome	0.000246	0.00063	CcSEcCtD
Midodrine—Nausea—Levetiracetam—epilepsy syndrome	0.000246	0.00063	CcSEcCtD
Midodrine—Rash—Vigabatrin—epilepsy syndrome	0.000246	0.000629	CcSEcCtD
Midodrine—Dizziness—Felbamate—epilepsy syndrome	0.000245	0.000628	CcSEcCtD
Midodrine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000245	0.000628	CcSEcCtD
Midodrine—Urethral disorder—Topiramate—epilepsy syndrome	0.000245	0.000628	CcSEcCtD
Midodrine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000245	0.000627	CcSEcCtD
Midodrine—Headache—Vigabatrin—epilepsy syndrome	0.000244	0.000625	CcSEcCtD
Midodrine—Hypertension—Pregabalin—epilepsy syndrome	0.000244	0.000624	CcSEcCtD
Midodrine—Rash—Diazepam—epilepsy syndrome	0.000242	0.000619	CcSEcCtD
Midodrine—Dermatitis—Diazepam—epilepsy syndrome	0.000242	0.000618	CcSEcCtD
Midodrine—Dizziness—Zonisamide—epilepsy syndrome	0.00024	0.000615	CcSEcCtD
Midodrine—Headache—Diazepam—epilepsy syndrome	0.00024	0.000615	CcSEcCtD
Midodrine—Anxiety—Pregabalin—epilepsy syndrome	0.00024	0.000613	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000239	0.000611	CcSEcCtD
Midodrine—Asthenia—Carbamazepine—epilepsy syndrome	0.000238	0.00061	CcSEcCtD
Midodrine—Agitation—Gabapentin—epilepsy syndrome	0.000238	0.000609	CcSEcCtD
Midodrine—Nausea—Fosphenytoin—epilepsy syndrome	0.000237	0.000608	CcSEcCtD
Midodrine—Erythema multiforme—Topiramate—epilepsy syndrome	0.000237	0.000606	CcSEcCtD
Midodrine—ADRA1A—brain—epilepsy syndrome	0.000235	0.0187	CbGeAlD
Midodrine—Dry mouth—Pregabalin—epilepsy syndrome	0.000235	0.000602	CcSEcCtD
Midodrine—Pruritus—Carbamazepine—epilepsy syndrome	0.000235	0.000601	CcSEcCtD
Midodrine—Rash—Felbamate—epilepsy syndrome	0.000234	0.000599	CcSEcCtD
Midodrine—Dermatitis—Felbamate—epilepsy syndrome	0.000234	0.000599	CcSEcCtD
Midodrine—Headache—Felbamate—epilepsy syndrome	0.000233	0.000595	CcSEcCtD
Midodrine—Confusional state—Pregabalin—epilepsy syndrome	0.000232	0.000595	CcSEcCtD
Midodrine—Cardiac disorder—Topiramate—epilepsy syndrome	0.000232	0.000595	CcSEcCtD
Midodrine—Flushing—Topiramate—epilepsy syndrome	0.000232	0.000595	CcSEcCtD
Midodrine—Dizziness—Clonazepam—epilepsy syndrome	0.000232	0.000593	CcSEcCtD
Midodrine—Nausea—Vigabatrin—epilepsy syndrome	0.000231	0.000592	CcSEcCtD
Midodrine—Insomnia—Valproic Acid—epilepsy syndrome	0.000231	0.00059	CcSEcCtD
Midodrine—Asthenia—Lamotrigine—epilepsy syndrome	0.00023	0.000589	CcSEcCtD
Midodrine—Dizziness—Phenytoin—epilepsy syndrome	0.00023	0.000589	CcSEcCtD
Midodrine—Rash—Zonisamide—epilepsy syndrome	0.000229	0.000586	CcSEcCtD
Midodrine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000229	0.000586	CcSEcCtD
Midodrine—Dermatitis—Zonisamide—epilepsy syndrome	0.000229	0.000586	CcSEcCtD
Midodrine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000229	0.000586	CcSEcCtD
Midodrine—Nausea—Diazepam—epilepsy syndrome	0.000228	0.000583	CcSEcCtD
Midodrine—Headache—Zonisamide—epilepsy syndrome	0.000228	0.000583	CcSEcCtD
Midodrine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000227	0.000582	CcSEcCtD
Midodrine—Angiopathy—Topiramate—epilepsy syndrome	0.000227	0.000581	CcSEcCtD
Midodrine—Pruritus—Lamotrigine—epilepsy syndrome	0.000227	0.000581	CcSEcCtD
Midodrine—Somnolence—Valproic Acid—epilepsy syndrome	0.000227	0.00058	CcSEcCtD
Midodrine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000226	0.000579	CcSEcCtD
Midodrine—Tachycardia—Pregabalin—epilepsy syndrome	0.000225	0.000576	CcSEcCtD
Midodrine—Chills—Topiramate—epilepsy syndrome	0.000225	0.000575	CcSEcCtD
Midodrine—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000224	0.000575	CcSEcCtD
Midodrine—Skin disorder—Pregabalin—epilepsy syndrome	0.000224	0.000573	CcSEcCtD
Midodrine—Hypertension—Gabapentin—epilepsy syndrome	0.000224	0.000572	CcSEcCtD
Midodrine—Rash—Clonazepam—epilepsy syndrome	0.000221	0.000565	CcSEcCtD
Midodrine—Dermatitis—Clonazepam—epilepsy syndrome	0.000221	0.000565	CcSEcCtD
Midodrine—Nausea—Felbamate—epilepsy syndrome	0.00022	0.000564	CcSEcCtD
Midodrine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00022	0.000564	CcSEcCtD
Midodrine—Anxiety—Gabapentin—epilepsy syndrome	0.00022	0.000563	CcSEcCtD
Midodrine—Dizziness—Carbamazepine—epilepsy syndrome	0.00022	0.000562	CcSEcCtD
Midodrine—Headache—Clonazepam—epilepsy syndrome	0.000219	0.000562	CcSEcCtD
Midodrine—Rash—Phenytoin—epilepsy syndrome	0.000219	0.000561	CcSEcCtD
Midodrine—Mental disorder—Topiramate—epilepsy syndrome	0.000219	0.000561	CcSEcCtD
Midodrine—Dermatitis—Phenytoin—epilepsy syndrome	0.000219	0.000561	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000219	0.000561	CcSEcCtD
Midodrine—Rash—Oxcarbazepine—epilepsy syndrome	0.000218	0.000558	CcSEcCtD
Midodrine—Pain—Valproic Acid—epilepsy syndrome	0.000218	0.000558	CcSEcCtD
Midodrine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000218	0.000558	CcSEcCtD
Midodrine—Headache—Phenytoin—epilepsy syndrome	0.000218	0.000558	CcSEcCtD
Midodrine—Headache—Oxcarbazepine—epilepsy syndrome	0.000217	0.000555	CcSEcCtD
Midodrine—Nausea—Zonisamide—epilepsy syndrome	0.000216	0.000553	CcSEcCtD
Midodrine—Dry mouth—Gabapentin—epilepsy syndrome	0.000216	0.000552	CcSEcCtD
Midodrine—Flatulence—Topiramate—epilepsy syndrome	0.000215	0.00055	CcSEcCtD
Midodrine—Tension—Topiramate—epilepsy syndrome	0.000214	0.000547	CcSEcCtD
Midodrine—Confusional state—Gabapentin—epilepsy syndrome	0.000213	0.000546	CcSEcCtD
Midodrine—Dizziness—Lamotrigine—epilepsy syndrome	0.000212	0.000543	CcSEcCtD
Midodrine—Nervousness—Topiramate—epilepsy syndrome	0.000212	0.000542	CcSEcCtD
Midodrine—Back pain—Topiramate—epilepsy syndrome	0.000211	0.00054	CcSEcCtD
Midodrine—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.00021	0.000538	CcSEcCtD
Midodrine—Muscle spasms—Topiramate—epilepsy syndrome	0.00021	0.000536	CcSEcCtD
Midodrine—Rash—Carbamazepine—epilepsy syndrome	0.000209	0.000536	CcSEcCtD
Midodrine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000209	0.000535	CcSEcCtD
Midodrine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000209	0.000534	CcSEcCtD
Midodrine—Insomnia—Pregabalin—epilepsy syndrome	0.000209	0.000534	CcSEcCtD
Midodrine—Nausea—Clonazepam—epilepsy syndrome	0.000208	0.000532	CcSEcCtD
Midodrine—Headache—Carbamazepine—epilepsy syndrome	0.000208	0.000532	CcSEcCtD
Midodrine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000207	0.000531	CcSEcCtD
Midodrine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000207	0.00053	CcSEcCtD
Midodrine—Nausea—Phenytoin—epilepsy syndrome	0.000207	0.000529	CcSEcCtD
Midodrine—Tachycardia—Gabapentin—epilepsy syndrome	0.000206	0.000528	CcSEcCtD
Midodrine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000206	0.000526	CcSEcCtD
Midodrine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000206	0.000526	CcSEcCtD
Midodrine—Skin disorder—Gabapentin—epilepsy syndrome	0.000205	0.000526	CcSEcCtD
Midodrine—Somnolence—Pregabalin—epilepsy syndrome	0.000205	0.000525	CcSEcCtD
Midodrine—Rash—Lamotrigine—epilepsy syndrome	0.000202	0.000518	CcSEcCtD
Midodrine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000202	0.000517	CcSEcCtD
Midodrine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000202	0.000516	CcSEcCtD
Midodrine—Headache—Lamotrigine—epilepsy syndrome	0.000201	0.000515	CcSEcCtD
Midodrine—Agitation—Topiramate—epilepsy syndrome	0.0002	0.000513	CcSEcCtD
Midodrine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000199	0.000509	CcSEcCtD
Midodrine—Nausea—Carbamazepine—epilepsy syndrome	0.000197	0.000505	CcSEcCtD
Midodrine—Pain—Pregabalin—epilepsy syndrome	0.000197	0.000505	CcSEcCtD
Midodrine—CYP2D6—head—epilepsy syndrome	0.000191	0.0152	CbGeAlD
Midodrine—Insomnia—Gabapentin—epilepsy syndrome	0.000191	0.000489	CcSEcCtD
Midodrine—Nausea—Lamotrigine—epilepsy syndrome	0.000191	0.000488	CcSEcCtD
Midodrine—Feeling abnormal—Pregabalin—epilepsy syndrome	0.00019	0.000486	CcSEcCtD
Midodrine—Paraesthesia—Gabapentin—epilepsy syndrome	0.00019	0.000486	CcSEcCtD
Midodrine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000189	0.000483	CcSEcCtD
Midodrine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000188	0.000482	CcSEcCtD
Midodrine—Hypertension—Topiramate—epilepsy syndrome	0.000188	0.000482	CcSEcCtD
Midodrine—Somnolence—Gabapentin—epilepsy syndrome	0.000188	0.000481	CcSEcCtD
Midodrine—Dyspepsia—Gabapentin—epilepsy syndrome	0.000186	0.000476	CcSEcCtD
Midodrine—Anxiety—Topiramate—epilepsy syndrome	0.000185	0.000473	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000184	0.000472	CcSEcCtD
Midodrine—Asthenia—Valproic Acid—epilepsy syndrome	0.000183	0.000468	CcSEcCtD
Midodrine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000183	0.000467	CcSEcCtD
Midodrine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000182	0.000467	CcSEcCtD
Midodrine—Dry mouth—Topiramate—epilepsy syndrome	0.000181	0.000464	CcSEcCtD
Midodrine—CYP2D6—nervous system—epilepsy syndrome	0.000181	0.0144	CbGeAlD
Midodrine—Pain—Gabapentin—epilepsy syndrome	0.000181	0.000463	CcSEcCtD
Midodrine—Pruritus—Valproic Acid—epilepsy syndrome	0.00018	0.000462	CcSEcCtD
Midodrine—Confusional state—Topiramate—epilepsy syndrome	0.000179	0.000459	CcSEcCtD
Midodrine—CYP2D6—central nervous system—epilepsy syndrome	0.000175	0.0139	CbGeAlD
Midodrine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000174	0.000446	CcSEcCtD
Midodrine—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000174	0.000446	CcSEcCtD
Midodrine—Tachycardia—Topiramate—epilepsy syndrome	0.000174	0.000444	CcSEcCtD
Midodrine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000173	0.000443	CcSEcCtD
Midodrine—Skin disorder—Topiramate—epilepsy syndrome	0.000173	0.000442	CcSEcCtD
Midodrine—CYP2D6—cerebellum—epilepsy syndrome	0.000171	0.0135	CbGeAlD
Midodrine—Dizziness—Valproic Acid—epilepsy syndrome	0.000169	0.000432	CcSEcCtD
Midodrine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000167	0.000428	CcSEcCtD
Midodrine—Asthenia—Pregabalin—epilepsy syndrome	0.000165	0.000423	CcSEcCtD
Midodrine—Pruritus—Pregabalin—epilepsy syndrome	0.000163	0.000418	CcSEcCtD
Midodrine—Insomnia—Topiramate—epilepsy syndrome	0.000161	0.000412	CcSEcCtD
Midodrine—Rash—Valproic Acid—epilepsy syndrome	0.000161	0.000412	CcSEcCtD
Midodrine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000161	0.000411	CcSEcCtD
Midodrine—Headache—Valproic Acid—epilepsy syndrome	0.00016	0.000409	CcSEcCtD
Midodrine—Paraesthesia—Topiramate—epilepsy syndrome	0.00016	0.000409	CcSEcCtD
Midodrine—Dyspnoea—Topiramate—epilepsy syndrome	0.000159	0.000406	CcSEcCtD
Midodrine—Somnolence—Topiramate—epilepsy syndrome	0.000158	0.000405	CcSEcCtD
Midodrine—Dyspepsia—Topiramate—epilepsy syndrome	0.000157	0.000401	CcSEcCtD
Midodrine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000154	0.000393	CcSEcCtD
Midodrine—Dizziness—Pregabalin—epilepsy syndrome	0.000152	0.00039	CcSEcCtD
Midodrine—Pain—Topiramate—epilepsy syndrome	0.000152	0.000389	CcSEcCtD
Midodrine—Asthenia—Gabapentin—epilepsy syndrome	0.000152	0.000388	CcSEcCtD
Midodrine—Nausea—Valproic Acid—epilepsy syndrome	0.000151	0.000388	CcSEcCtD
Midodrine—Pruritus—Gabapentin—epilepsy syndrome	0.00015	0.000383	CcSEcCtD
Midodrine—Feeling abnormal—Topiramate—epilepsy syndrome	0.000147	0.000375	CcSEcCtD
Midodrine—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000145	0.000372	CcSEcCtD
Midodrine—Rash—Pregabalin—epilepsy syndrome	0.000145	0.000372	CcSEcCtD
Midodrine—Dermatitis—Pregabalin—epilepsy syndrome	0.000145	0.000372	CcSEcCtD
Midodrine—Headache—Pregabalin—epilepsy syndrome	0.000144	0.00037	CcSEcCtD
Midodrine—Abdominal pain—Topiramate—epilepsy syndrome	0.000141	0.00036	CcSEcCtD
Midodrine—Dizziness—Gabapentin—epilepsy syndrome	0.00014	0.000358	CcSEcCtD
Midodrine—CYP2D6—brain—epilepsy syndrome	0.000139	0.011	CbGeAlD
Midodrine—Nausea—Pregabalin—epilepsy syndrome	0.000137	0.000351	CcSEcCtD
Midodrine—Rash—Gabapentin—epilepsy syndrome	0.000133	0.000341	CcSEcCtD
Midodrine—Dermatitis—Gabapentin—epilepsy syndrome	0.000133	0.000341	CcSEcCtD
Midodrine—Headache—Gabapentin—epilepsy syndrome	0.000132	0.000339	CcSEcCtD
Midodrine—Asthenia—Topiramate—epilepsy syndrome	0.000128	0.000327	CcSEcCtD
Midodrine—Pruritus—Topiramate—epilepsy syndrome	0.000126	0.000322	CcSEcCtD
Midodrine—Nausea—Gabapentin—epilepsy syndrome	0.000126	0.000321	CcSEcCtD
Midodrine—Dizziness—Topiramate—epilepsy syndrome	0.000118	0.000301	CcSEcCtD
Midodrine—Rash—Topiramate—epilepsy syndrome	0.000112	0.000287	CcSEcCtD
Midodrine—Dermatitis—Topiramate—epilepsy syndrome	0.000112	0.000287	CcSEcCtD
Midodrine—Headache—Topiramate—epilepsy syndrome	0.000111	0.000285	CcSEcCtD
Midodrine—Nausea—Topiramate—epilepsy syndrome	0.000106	0.00027	CcSEcCtD
Midodrine—ADRA1D—Signaling Pathways—CRH—epilepsy syndrome	2.79e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL3—epilepsy syndrome	2.79e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—OXT—epilepsy syndrome	2.79e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CDC42—epilepsy syndrome	2.78e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GABBR1—epilepsy syndrome	2.77e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	2.76e-05	0.000169	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR5—epilepsy syndrome	2.75e-05	0.000169	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HBEGF—epilepsy syndrome	2.75e-05	0.000169	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CDC42—epilepsy syndrome	2.72e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GAL—epilepsy syndrome	2.72e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GFAP—epilepsy syndrome	2.72e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT3—epilepsy syndrome	2.7e-05	0.000166	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR2A—epilepsy syndrome	2.7e-05	0.000166	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AVP—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GRM5—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP2—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CHRM3—epilepsy syndrome	2.69e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HRH3—epilepsy syndrome	2.65e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AVP—epilepsy syndrome	2.63e-05	0.000161	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—OPRM1—epilepsy syndrome	2.61e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.6e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTK2B—epilepsy syndrome	2.6e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TSC1—epilepsy syndrome	2.6e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.57e-05	0.000158	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	2.57e-05	0.000158	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	2.57e-05	0.000158	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AGT—epilepsy syndrome	2.56e-05	0.000157	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR2—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NTRK2—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SST—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR5—epilepsy syndrome	2.52e-05	0.000155	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	2.51e-05	0.000154	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DUSP6—epilepsy syndrome	2.5e-05	0.000154	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRA2A—epilepsy syndrome	2.47e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	2.47e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR3—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PLAT—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	2.46e-05	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	2.41e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ATP2A2—epilepsy syndrome	2.4e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NPY—epilepsy syndrome	2.4e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	2.39e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—BDKRB2—epilepsy syndrome	2.37e-05	0.000146	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL12—epilepsy syndrome	2.37e-05	0.000146	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—POMC—epilepsy syndrome	2.37e-05	0.000146	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	2.37e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PRKCB—epilepsy syndrome	2.36e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	2.35e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6ST—epilepsy syndrome	2.35e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AGT—epilepsy syndrome	2.34e-05	0.000144	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JUNB—epilepsy syndrome	2.33e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CNR1—epilepsy syndrome	2.33e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PLCB1—epilepsy syndrome	2.32e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CRH—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL3—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—OXT—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL2—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HSPB1—epilepsy syndrome	2.32e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR5—epilepsy syndrome	2.29e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR7—epilepsy syndrome	2.27e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR2A—epilepsy syndrome	2.24e-05	0.000137	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.24e-05	0.000137	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.21e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HBEGF—epilepsy syndrome	2.21e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	2.19e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.19e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT3—epilepsy syndrome	2.17e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.16e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TSC1—epilepsy syndrome	2.15e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTK2B—epilepsy syndrome	2.15e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—POMC—epilepsy syndrome	2.15e-05	0.000132	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.15e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	2.13e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AGT—epilepsy syndrome	2.12e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADAM10—epilepsy syndrome	2.12e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL2—epilepsy syndrome	2.11e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NTRK2—epilepsy syndrome	2.1e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR2—epilepsy syndrome	2.1e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SST—epilepsy syndrome	2.1e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DUSP6—epilepsy syndrome	2.08e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	2.08e-05	0.000127	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	2.06e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	2.06e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	2.06e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	2.06e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	2.06e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRA2A—epilepsy syndrome	2.05e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLAT—epilepsy syndrome	2.04e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	2.03e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—S100B—epilepsy syndrome	2e-05	0.000123	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.99e-05	0.000122	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SOCS3—epilepsy syndrome	1.98e-05	0.000122	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDC42—epilepsy syndrome	1.98e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.97e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.97e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.97e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.96e-05	0.00012	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.94e-05	0.000119	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.94e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JUNB—epilepsy syndrome	1.93e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CNR1—epilepsy syndrome	1.93e-05	0.000119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.93e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.92e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	1.91e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AVP—epilepsy syndrome	1.91e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.91e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	1.89e-05	0.000116	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	1.89e-05	0.000116	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	1.86e-05	0.000114	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	1.86e-05	0.000114	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.86e-05	0.000114	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.85e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.83e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.82e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	1.81e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HES1—epilepsy syndrome	1.81e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	1.8e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FYN—epilepsy syndrome	1.76e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.76e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.75e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.75e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.75e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.75e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.75e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.75e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.74e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	1.72e-05	0.000105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	1.72e-05	0.000105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.71e-05	0.000105	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.69e-05	0.000104	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	1.68e-05	0.000103	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	1.67e-05	0.000103	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	1.66e-05	0.000102	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.63e-05	9.99e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	1.63e-05	9.99e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	1.6e-05	9.81e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	1.59e-05	9.75e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	1.59e-05	9.75e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.59e-05	9.73e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.56e-05	9.58e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.55e-05	9.54e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.54e-05	9.49e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.54e-05	9.43e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	1.51e-05	9.29e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	1.51e-05	9.28e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.5e-05	9.22e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	1.48e-05	9.09e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.48e-05	9.06e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.46e-05	8.97e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.46e-05	8.97e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.46e-05	8.95e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.46e-05	8.94e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.45e-05	8.92e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	1.45e-05	8.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.41e-05	8.66e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.4e-05	8.62e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	1.4e-05	8.57e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	1.39e-05	8.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.39e-05	8.52e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.35e-05	8.29e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.33e-05	8.19e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.32e-05	8.12e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.32e-05	8.1e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.31e-05	8.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.3e-05	7.97e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.29e-05	7.94e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.29e-05	7.92e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	1.27e-05	7.81e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	1.26e-05	7.71e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	1.25e-05	7.7e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.25e-05	7.69e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.25e-05	7.66e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	1.24e-05	7.64e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.24e-05	7.61e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.23e-05	7.58e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.23e-05	7.57e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.23e-05	7.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.2e-05	7.39e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.2e-05	7.37e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.17e-05	7.21e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.16e-05	7.12e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-05	7.09e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	1.12e-05	6.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.12e-05	6.85e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.11e-05	6.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.09e-05	6.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.07e-05	6.57e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.06e-05	6.48e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.04e-05	6.41e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-05	6.34e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.03e-05	6.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.03e-05	6.32e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.03e-05	6.29e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.02e-05	6.29e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.02e-05	6.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.89e-06	6.08e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	9.5e-06	5.84e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	9.42e-06	5.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	9.37e-06	5.76e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	9.33e-06	5.73e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.2e-06	5.65e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	9.17e-06	5.63e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	9.15e-06	5.62e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	8.9e-06	5.46e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	8.66e-06	5.32e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	8.63e-06	5.3e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	8.5e-06	5.22e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	8.29e-06	5.09e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	8.2e-06	5.04e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—epilepsy syndrome	8.06e-06	4.95e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	7.99e-06	4.91e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.9e-06	4.85e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.89e-06	4.84e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	7.81e-06	4.8e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	7.7e-06	4.73e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	7.59e-06	4.66e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	7.55e-06	4.63e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	7.38e-06	4.53e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	7.16e-06	4.4e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.01e-06	4.3e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	6.94e-06	4.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	6.81e-06	4.18e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.79e-06	4.17e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	6.74e-06	4.14e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.63e-06	4.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	6.56e-06	4.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.36e-06	3.91e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.19e-06	3.8e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	6.05e-06	3.71e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.89e-06	3.62e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.41e-06	3.32e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	5.1e-06	3.13e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	4.23e-06	2.6e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	3.76e-06	2.31e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.72e-06	1.67e-05	CbGpPWpGaD
